Sunshine Biopharma, Inc. (SBFM) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SBFM Revenue Growth
SBFM Revenue Analysis (2013–2024)
As of May 8, 2026, Sunshine Biopharma, Inc. (SBFM) generated trailing twelve-month (TTM) revenue of $36.3 million, reflecting modest growth of +1.2% year-over-year. The most recent quarter (Q2 2025) recorded $9.4 million in revenue, up 5.7% sequentially.
Looking at the longer-term picture, SBFM's 5-year compound annual growth rate (CAGR) stands at +340.1%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $34.9 million in 2024, representing a new all-time high.
When compared to Healthcare sector peers including NUVB (+1205.5% YoY), TPVG, and SNDX (+396.7% YoY), SBFM has underperformed the peer group in terms of revenue growth. Compare SBFM vs NUVB →
SBFM Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SBFMCurrent | $36M | +1.2% | +340.1% | -16.7% | |
 NUVB | $63M | +1205.5% | - | -338.7% | |
 TPVG | $97M | - | - | 77.9% | |
 SNDX | $172M | +396.7% | +157.7% | -158.4% |
SBFM Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $34.9M | +44.7% | $10.7M | 30.6% | $-5,812,000 | -16.7% |
| 2023 | $24.1M | +454.4% | $8.3M | 34.6% | $-4,785,000 | -19.9% |
| 2022 | $4.3M | +1802.6% | $1.7M | 39.0% | $-27,001,000 | -621.3% |
| 2021 | $228K | +219.9% | $111K | 48.4% | $-2,440,000 | -1068.2% |
| 2020 | $71K | +238.1% | $46K | 63.8% | $-576,874 | -807.8% |
| 2019 | $21K | -95.3% | $10K | 47.7% | $-641,636 | -3037.9% |
| 2018 | $447K | - | $56K | 12.5% | $-1,167,000 | -261.0% |
| 2017 | $0 | - | $-6,629 | - | $-857,190 | - |
| 2016 | $0 | -100.0% | $-60,731 | - | $-993,108 | - |
| 2015 | $2K | - | $-383,000 | -22423.9% | $-780,000 | -45667.4% |
See SBFM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SBFM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SBFM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSBFM — Frequently Asked Questions
Quick answers to the most common questions about buying SBFM stock.
Is SBFM's revenue growth accelerating or slowing?
SBFM revenue growth slowed to +1.2%, below the 5-year CAGR of +340.1%. TTM revenue is $36M. The deceleration marks a shift from historical growth rates.
What is SBFM's long-term revenue growth rate?
Sunshine Biopharma, Inc.'s 5-year revenue CAGR of +340.1% reflects the variable expansion pattern. Current YoY growth of +1.2% is near this long-term average.
How is SBFM's revenue distributed by segment?
SBFM reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.